NOT:ETR
Novartis
137,04 €
arrow_upward
+0,41%(+0,56) 1 d.
21. 10., 17:35:53 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NOT…
Otvoriť
136,56 €
Vysoká
137,28 €
Nízka
136,02 €
Trh. kap.
311,79 mld.
Priem. obj.
7,35 tis.
Objem
2,79 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Otvoriť
136,56 €
Vysoká
137,28 €
Nízka
136,02 €
Trh. kap.
311,79 mld.
Priem. obj.
7,35 tis.
Objem
2,79 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 54 minútami
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
AD HOC NEWS
·
pred 1 hodinou
Novartis stock: UBS keeps Hold rating and CHF 116.00 target for Novartis stock
AD HOC NEWS
·
pred 9 hodinami
Novartis stock has investor call on October 23 ahead of Xetra open
CNBC
·
pred 1 mesiacom
Pharma major Novartis falls 10% after three drug trial setbacks
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Informácie o subjekte Novartis
Generálny riaditeľVasant Narasimhan
Zamestnanci75,3 tis.
Dátum založenia7. 3. 1996
Hlavné sídloBazilej, Bazilej-mesto, Švajčiarsko
Odvetvie-
Webnovartis.com